Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries.

Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries.
复制标题

DOI:
10.1016/j.parkreldis.2018.02.008
复制
发表时间:
2018-05
影响因子:
4.1
通讯作者:
Racette BA
Racette BA
中科院分区:
医学2区
文献类型:
--
作者:
Camacho-Soto A;Gross A;Searles Nielsen S;Dey N;Racette BA

文献摘要

参考文献

被引文献

相似文献

胃肠道(GI)功能障碍先于帕金森病(PD)的运动症状数年。PD患者存在肠道α-突触核蛋白的异常聚集,炎症反应可能促进了α-突触核蛋白的聚集。肠道α-突触核蛋白聚集体与中枢神经系统神经病理学之间的关系尚不清楚。最近,我们观察到炎症性肠病(IBD)和PD之间可能存在负相关,作为PD预测模型的一部分。因此,本研究的目的是检查PD风险与IBD以及IBD相关疾病和治疗之间的关系。采用病例对照设计,我们使用2004-2009年的综合医疗保险数据(包括详细的索赔数据)确定了89,790例新诊断的PD病例和118,095例基于人群的对照,年龄> 65岁。我们使用国际疾病分类第9版(ICD-9)诊断代码对IBD进行分类。我们使用逻辑回归计算比值比(OR)和95%置信区间(CI),以评估PD和IBD之间的关联。协变量包括年龄、性别、人种/种族、吸烟、Elixhauser合并症和医疗保健使用。PD与总体IBD(OR = 0.85,95% CI 0.80-0.91)以及克罗恩病(OR = 0.83,95% CI 0.74-0.93)和溃疡性结肠炎(OR = 0.88,95% CI 0.82- 0.96)呈负相关。在IBD ICD-9编码≥ 2个的受益人中,IBD ICD-9编码数量(作为IBD严重程度的潜在指标)与PD之间存在反向剂量反应相关性(趋势p = 0.006)。IBD与发生PD的风险较低相关。
Gastrointestinal (GI) dysfunction precedes the motor symptoms of Parkinson’s disease (PD) by several years. PD patients have abnormal aggregation of intestinal α-synuclein, the accumulation of which may be promoted by inflammation. The relationship between intestinal α-synuclein aggregates and central nervous system neuropathology is unknown. Recently, we observed a possible inverse association between inflammatory bowel disease (IBD) and PD as part of a predictive model of PD. Therefore, the objective of this study was to examine the relationship between PD risk and IBD and IBD-associated conditions and treatment. Using a case-control design, we identified 89,790 newly diagnosed PD cases and 118,095 population-based controls > 65 years of age using comprehensive Medicare data from 2004–2009 including detailed claims data. We classified IBD using International Classification of Diseases version 9 (ICD-9) diagnosis codes. We used logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the association between PD and IBD. Covariates included age, sex, race/ethnicity, smoking, Elixhauser comorbidities, and health care use. PD was inversely associated with IBD overall (OR = 0.85, 95% CI 0.80–0.91) and with both Crohn’s disease (OR = 0.83, 95% CI 0.74–0.93) and ulcerative colitis (OR = 0.88, 95% CI 0.82– 0.96). Among beneficiaries with ≥ 2 ICD-9 codes for IBD, there was an inverse dose-response association between number of IBD ICD-9 codes, as a potential proxy for IBD severity, and PD (p-for-trend = 0.006). IBD is associated with a lower risk of developing PD.
DOI: 10.1016/s1474-4422(14)70287-x
发表时间: 2015-01-01
期刊: LANCET NEUROLOGY
影响因子: 48
作者:
Schrag, Anette;Horsfall, Laura;Petersen, Irene
通讯作者: Petersen, Irene
DOI: 10.1002/ana.10277
发表时间: 2002-09-01
影响因子: 11.2
作者:
Hernán, MA;Takkouche, B;Gestal-Otero, JJ
通讯作者: Gestal-Otero, JJ
DOI: 10.1212/wnl.0000000000004536
发表时间: 2017-10-03
期刊: NEUROLOGY
影响因子: 9.9
作者:
Nielsen, Susan Searles;Warden, Mark N.;Racette, Brad A.
通讯作者: Racette, Brad A.
DOI: 10.1016/j.expneurol.2005.10.034
发表时间: 2006-02-01
影响因子: 5.3
作者:
Miklossy, J;Doudet, DD;McGeer, PL
通讯作者: McGeer, PL
DOI: 10.1111/j.1471-4159.2010.06879.x
发表时间: 2010-09-01
影响因子: 4.7
作者:
Villaran, Ruth F.;Espinosa-Oliva, Ana M.;Machado, Alberto
通讯作者: Machado, Alberto